Xiaoling Ou
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Gastric Cancer Management and Outcomes 2
- Lung Cancer Diagnosis and Treatment 1
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
-
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 2
- Co-authors
- Mireille Cantarini (7 shared papers)Myung‐Ju Ahn (7 shared papers)Byoung Chul Cho (4 shared papers)James Chih‐Hsin Yang (6 shared papers)Paul Frewer (5 shared papers)Dariusz M. Kowalski (4 shared papers)Helena A. Yu (5 shared papers)Ji‐Youn Han (5 shared papers)
- Journals
- Journal of Thoracic Oncology (2 papers)Annals of Oncology (2 papers)Clinical Cancer Research (1 paper)Ophthalmology (1 paper)Targeted Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Xiaoling Ou
12 papers receiving 566 citations
Hit Papers
Peers
Comparison fields: 5 of 50
- Pulmonary and Respiratory Medicine 409
- Oncology 276
- Ophthalmology 84
- Hepatology 53
- Cancer Research 78
Countries citing papers authored by Xiaoling Ou
This map shows the geographic impact of Xiaoling Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Ou more than expected).
Fields of papers citing papers by Xiaoling Ou
This network shows the impact of papers produced by Xiaoling Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Ou. The network helps show where Xiaoling Ou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study Hit paper breakdown → | 2020 | 295 |
| 2 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON Hit paper breakdown → | 2022 | 95 |
| 3 | 2011 | 53 | |
| 4 | 2022 | 50 | |
| 5 | 2011 | 36 | |
| 6 | 2017 | 17 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 1 |
About Xiaoling Ou
Xiaoling Ou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Genetics, having authored 12 papers that have together received 573 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Gastric Cancer Management and Outcomes (2 papers), Lung Cancer Diagnosis and Treatment (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (409 citations), Oncology (276 citations), Ophthalmology (84 citations), Hepatology (53 citations) and Cancer Research (78 citations). Xiaoling Ou has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Mireille Cantarini, Myung‐Ju Ahn, Byoung Chul Cho, James Chih‐Hsin Yang, Paul Frewer, Dariusz M. Kowalski, Helena A. Yu, Ji‐Youn Han, Wu‐Chou Su and Lecia V. Sequist. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Clinical Cancer Research, Ophthalmology and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.